DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,060,160 | -43.0% | 2,374,285 | -44.9% | 1.39% | +23.4% |
| Q2 2023 | $1,033,948,208 | -5.5% | 4,308,118 | -0.8% | 1.13% | -6.7% |
| Q1 2023 | $1,094,024,582 | +132.1% | 4,340,678 | +97.8% | 1.21% | -23.5% |
| Q4 2022 | $471,314,156 | -16.9% | 2,193,928 | -0.1% | 1.58% | +3.6% |
| Q3 2022 | $567,169,000 | +5.4% | 2,195,865 | +3.5% | 1.53% | +9.4% |
| Q2 2022 | $538,076,000 | -6.5% | 2,122,423 | +8.2% | 1.40% | +11.2% |
| Q1 2022 | $575,263,000 | -15.9% | 1,961,139 | -5.7% | 1.26% | -11.5% |
| Q4 2021 | $684,419,000 | +8.4% | 2,080,241 | +0.3% | 1.42% | -3.4% |
| Q3 2021 | $631,516,000 | +13.4% | 2,074,350 | -0.1% | 1.47% | +14.9% |
| Q2 2021 | $556,955,000 | +15.9% | 2,075,406 | -2.8% | 1.28% | +5.7% |
| Q1 2021 | $480,753,000 | -11.0% | 2,135,929 | -12.1% | 1.21% | -15.2% |
| Q4 2020 | $539,971,000 | -6.1% | 2,430,768 | -9.0% | 1.43% | -19.0% |
| Q3 2020 | $574,933,000 | +57.9% | 2,670,872 | +29.7% | 1.76% | -0.5% |
| Q2 2020 | $364,198,000 | -5.0% | 2,059,594 | -25.6% | 1.77% | +7.7% |
| Q1 2020 | $383,364,000 | -11.2% | 2,769,773 | -1.5% | 1.64% | +16.8% |
| Q4 2019 | $431,734,000 | +6.8% | 2,812,967 | +0.5% | 1.41% | -0.9% |
| Q3 2019 | $404,063,000 | +8.6% | 2,797,640 | +7.5% | 1.42% | +8.8% |
| Q2 2019 | $372,048,000 | +25.1% | 2,603,183 | +15.5% | 1.31% | +13.9% |
| Q1 2019 | $297,429,000 | +29.6% | 2,252,915 | +1.2% | 1.15% | +12.1% |
| Q4 2018 | $229,529,000 | -3.7% | 2,225,845 | +1.4% | 1.02% | +13.2% |
| Q3 2018 | $238,422,000 | +9.8% | 2,194,208 | -0.3% | 0.90% | +2.1% |
| Q2 2018 | $217,086,000 | +2.3% | 2,199,910 | +1.5% | 0.88% | -4.0% |
| Q1 2018 | $212,147,000 | +4.9% | 2,166,751 | -0.6% | 0.92% | +7.5% |
| Q4 2017 | $202,303,000 | +6.0% | 2,179,530 | -2.0% | 0.86% | -1.4% |
| Q3 2017 | $190,762,000 | +9.7% | 2,223,836 | +7.9% | 0.87% | -20.3% |
| Q2 2017 | $173,888,000 | +20.6% | 2,060,530 | +22.2% | 1.09% | +20.5% |
| Q1 2017 | $144,200,000 | +9.6% | 1,685,963 | -0.3% | 0.91% | +4.1% |
| Q4 2016 | $131,619,000 | +0.0% | 1,690,898 | +0.7% | 0.87% | -4.7% |
| Q3 2016 | $131,606,000 | -20.7% | 1,678,859 | +2.1% | 0.91% | -24.7% |
| Q2 2016 | $166,053,000 | +8.1% | 1,644,097 | +1.5% | 1.21% | +2.1% |
| Q1 2016 | $153,664,000 | +4.6% | 1,619,892 | +2.5% | 1.19% | +3.3% |
| Q4 2015 | $146,848,000 | +11.1% | 1,581,051 | +1.9% | 1.15% | +5.7% |
| Q3 2015 | $132,147,000 | +1.6% | 1,550,828 | +2.0% | 1.09% | +14.8% |
| Q2 2015 | $130,074,000 | +2.0% | 1,519,730 | +1.2% | 0.95% | +0.5% |
| Q1 2015 | $127,531,000 | +1.2% | 1,502,136 | +2.2% | 0.94% | -2.3% |
| Q4 2014 | $126,002,000 | +14.0% | 1,470,082 | +1.1% | 0.96% | +10.9% |
| Q3 2014 | $110,495,000 | -2.7% | 1,454,264 | +0.8% | 0.87% | -5.6% |
| Q2 2014 | $113,543,000 | +4.7% | 1,442,190 | +0.3% | 0.92% | -0.1% |
| Q1 2014 | $108,493,000 | – | 1,438,146 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |